Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine as Adjuvant for Femoral Nerve Block in TKA
NCT04642651Phase 4Completed
- Sponsor
- Peking University First Hospital
- Start
- Nov 2020
- Primary completion
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of dexmedetomidine in osteoarthritis (OA) (2 arms), sponsored by Peking University First Hospital. Primary endpoint: Quality of life - mental component summary score at 3 months. Started Nov 2020; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT04642651.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04642651.